1:00
en
CR
31
TROMP : Delays host immune response
CHANCRE : Primary lesion
SECONDARY : Highly infectious stage
LATENT : No clinical manifestation; sero-reactive
LATE : Spirochetes are extremely sparse or absent
GUMMA : Soft gummy tumor
LECITHIN : Produces standard reactivity in VDRL
BENZOIC : VDRL stabilizer
HEATING : Inactivation of sample in VDRL
BOERNER : VDRL agglutination slide for CSF
REACTIVE : Large clumps
THIMEROSAL : RPR preservative
EDTA : RPR stabilizer
SODIUMAZIDE : TRUST preservative
TOLUIDINERED : Red pigment
MALARIA : Most common false-positive in NTTs
GUINEAPIG : Source of complement
GROUPANTIBODY : Major problem in TPI
FITC : FTA label
NICHOLS : FTA-ABS antigen
REITER : FTA-ABS absorbent
SHEEP : MHA-TP vehiculum
TURKEY : HATTS vehiculum
GLUTARALDEHYDE : HATTS stabilizer
CARPET : HATTS positive result
CHRONIC : FTA ABS reactive, TPI non-reactive
YAWS : Frambesia
PINTID : Carate papules
SLO : Oxygen-labile
RABBIT : ASOT indicator
TODD : ASOT unit
GREEN : DNB test positive result
NEUTRALIZATION : DNB test principle
STREPTOKINASE : Dissolves clot
METAMPHETAMINE : Shabu
Across:| 3. | Produces standard reactivity in VDRL | | 4. | FTA label | | 6. | ASOT indicator | | 7. | Large clumps | | 9. | No clinical manifestation; sero-reactive | | 13. | Inactivation of sample in VDRL | | 14. | Delays host immune response | | 15. | Soft gummy tumor | | 17. | FTA ABS reactive, TPI non-reactive |
| | 18. | RPR stabilizer | | 20. | Oxygen-labile | | 21. | Red pigment | | 22. | Dissolves clot | | 24. | VDRL stabilizer | | 25. | Major problem in TPI | | 28. | Carate papules | | 29. | Most common false-positive in NTTs | | 30. | MHA-TP vehiculum |
| | Down:| 1. | FTA-ABS absorbent | | 2. | HATTS stabilizer | | 5. | Source of complement | | 8. | HATTS positive result | | 10. | Primary lesion | | 11. | Spirochetes are extremely sparse or absent | | 12. | FTA-ABS antigen |
| | 16. | TRUST preservative | | 19. | Frambesia | | 21. | HATTS vehiculum | | 23. | Highly infectious stage | | 26. | ASOT unit | | 27. | VDRL agglutination slide for CSF |
| |
© 2016
PuzzleFast.com, Noncommercial Use Only
Across:| 3. | Produces standard reactivity in VDRL | | 4. | FTA label | | 6. | ASOT indicator | | 7. | Large clumps | | 9. | No clinical manifestation; sero-reactive | | 13. | Inactivation of sample in VDRL | | 14. | Delays host immune response | | 15. | Soft gummy tumor | | 17. | FTA ABS reactive, TPI non-reactive |
| | 18. | RPR stabilizer | | 20. | Oxygen-labile | | 21. | Red pigment | | 22. | Dissolves clot | | 24. | VDRL stabilizer | | 25. | Major problem in TPI | | 28. | Carate papules | | 29. | Most common false-positive in NTTs | | 30. | MHA-TP vehiculum |
| | Down:| 1. | FTA-ABS absorbent | | 2. | HATTS stabilizer | | 5. | Source of complement | | 8. | HATTS positive result | | 10. | Primary lesion | | 11. | Spirochetes are extremely sparse or absent | | 12. | FTA-ABS antigen |
| | 16. | TRUST preservative | | 19. | Frambesia | | 21. | HATTS vehiculum | | 23. | Highly infectious stage | | 26. | ASOT unit | | 27. | VDRL agglutination slide for CSF |
| |
© 2016
PuzzleFast.com, Noncommercial Use Only